Gilbert Cisneros · AGIO
Gilbert Cisneros's AGIO trades
- Transactions
- 5
- Buys / sells
- 5 / 0
- Disclosed range
- $5K – $75K
- Last filed
- 2026-09-10
AGIO transactions reported by Gilbert Cisneros
| Type | Owner | ||||
|---|---|---|---|---|---|
Agios Pharmaceuticals, Inc. - Common Stock AGIO | Purchase | Self | $1,001 - $15,000 | 2026-09-10 #20035390 | |
Agios Pharmaceuticals, Inc. - Common Stock AGIO | Purchase | Self | $1,001 - $15,000 | 2026-04-07 #20034285 | |
Agios Pharmaceuticals, Inc. - Common Stock AGIO | Purchase | Self | $1,001 - $15,000 | 2026-01-12 #20033762 | |
Agios Pharmaceuticals, Inc. - Common Stock AGIO | Purchase | Self | $1,001 - $15,000 | 2025-05-06 #20030288 | |
Agios Pharmaceuticals, Inc. - Common Stock AGIO | Purchase | Self | $1,001 - $15,000 | 2025-02-11 #20026726 |
A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.
The tracker is free
A STOCK Act row is evidence, not a model portfolio. Membership is the sourced monthly thesis around it.
More tickers reported by Gilbert Cisneros
Gilbert Cisneros and AGIO — questions
Did Gilbert Cisneros buy or sell AGIO?
House Clerk filings for 2025 and 2026 show 5 purchases and 0 sales of Agios Pharmaceuticals, Inc. - Common Stock (AGIO) reported by Gilbert Cisneros, between 2025-01-29 and 2026-08-20. Reported owner: Self.
How much AGIO did Gilbert Cisneros trade?
Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $5K – $75K across 5 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.
When was the last AGIO filing by Gilbert Cisneros?
The most recent periodic transaction report containing a AGIO row was filed on 2026-09-10. New filings appear in the House Clerk index and are picked up when the dataset is refreshed.
Yield Theory is not affiliated with any elected official or with Agios Pharmaceuticals, Inc. - Common Stock. Rows are parsed from public House Clerk periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.
Don’t copy the filing. Read the thesis.
Gilbert Cisneros AGIO disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $15/month or $150/year.
$15/mo or $150/yr · cancel future renewals anytime · sources included